PAR. SP, page-1027

I have kept a close eye on PAR since I sold our holdings at $2.59 in Nov 21, I wondered at the time whether I,d made a bad decision, as it turns out I didnt.
I read all of Mozz,s posts which are very detailed and others too but in spite of them the value keeps decreasing. I wonder now should I buy back in as it surely cant go much lower but I,ve thought that on several other occasions and been wrong.
The thing I find most concerning is that none of the big pharmers seem to be interested and at such a low value where they could afford to take the risk with little downside it would seem.
I,ll continue to monitor the stock and hope the FDA approves a third phase trial which will inevitably kick the price up, as I would prefer to buy into rising value rather than a falling one.
I wish all holders good luck